ACETYLATOR PHENOTYPE (AP) IN CHILDREN GIVEN SULFISOXAZOLE (SSZ) USING A MULTICOMPARTMENT PHARMACOKINETIC (PK) MODEL

被引：0
|
作者：
DOUIDAR, SM
DODGE, WF
SNODGRASS, WR
机构：
[1] TEXAS TECH UNIV,HLTH SCI CTR,DEPT PEDIAT,DIV CLIN PHARMACOL,AMARILLO,TX
[2] UNIV TEXAS,MED BRANCH,DEPT PEDIAT,GALVESTON,TX 77550
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1992年 / 51卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 38 条
  • [21] A population pharmacokinetic/pharmacodynamic (PK/PD) model to determine the bioequivalence of albuterol using rate and extent of absorption derived from FEV1 measurements.
    Marier, JF
    Ducharme, MP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P59 - P59
  • [22] INFLUENCE OF CO-MEDICATION AND URINE PH VALUES ON METHOTREXATE SERUM LEVELS IN CHILDREN PREDICTED BY THE GENERIC PHYSIOLOGY-BASED PHARMACOKINETIC (PBPK) MODEL PK-SIM®
    Adam, K.
    Schmiedl, S.
    Szymanski, J.
    Imschweiler, T.
    Niehues, T.
    Sinha, K.
    Wirth, S.
    Abu-Hejleh, A.
    Willmann, S.
    Coboeken, K.
    Lippert, J.
    Thuermann, P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 : 6 - 6
  • [23] Activity of Linezolid in an In Vitro Pharmacokinetic-Pharmacodynamic Model Using Different Dosages and Staphylococcus aureus and Enterococcus faecalis Strains with and without a Hypermutator Phenotype
    Ba, Boubakar B.
    Arpin, Corinne
    Nso, Branly Bikie Bi
    Dubois, Veronique
    Saux, Marie-Claude
    Quentin, Claudine
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (04) : 1443 - 1452
  • [24] INDIVIDUALIZED DOSING OF HYDROXYUREA FOR CHILDREN WITH SICKLE CELL ANEMIA USING A PHARMACOKINETIC-BASED MODEL; THE TREAT STUDY.
    McGann, P. T.
    Dong, M.
    Mizuno, T.
    Marahatta, A.
    Ware, R. E.
    Vinks, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S78
  • [25] Individualized Dosing of Hydroxyurea for Children with Sickle Cell Anemia Using a Population Pharmacokinetic-Based Model: The TREAT Study
    McGann, Patrick T.
    Dong, Min
    Marahatta, Anu
    Howard, Thad A.
    Mizuno, Tomoyuki
    Kalinyak, Karen A.
    Kalfa, Theodosia A.
    Malik, Punam
    Niss, Omar
    Quinn, Charles T.
    Ware, Russell E.
    Vinks, Alexander A.
    BLOOD, 2016, 128 (22)
  • [26] Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: A pediatric oncology group study
    Tubergen, DG
    Stewart, CF
    Pratt, CB
    Zamboni, WC
    Winick, N
    Santana, VM
    Dryer, ZA
    Kurtzberg, J
    Bell, B
    Grier, H
    Vietti, TJ
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (04) : 352 - 361
  • [27] Evaluation of desmopressin dosing in children with central diabetes insipidus using real-world data and pharmacokinetic/pharmacodynamic model simulations
    Yen, Kevin
    Hughes, Emma
    Savic, Rada
    Srinivasan, Shylaja
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 221 - 224
  • [28] RETRACTION: Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate (vol 38, pg 1847, 2021) (Retraction of Vol 38, Pg 1847, 2021)
    Ren, Chang
    Wang, Yao
    Zhang, Mei
    Kong, Dexuan
    Ning, Chen
    Cheng, Yujie
    Bian, Yueying
    Sun, Mengqi
    Su, Shengdi
    Wang, Yucong
    Zhang, Yongjie
    Lu, Yang
    Li, Ning
    Zhao, Di
    Chen, Xijing
    PHARMACEUTICAL RESEARCH, 2023, 40 (05) : 1311 - 1311
  • [29] Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform
    Chelle, Pierre
    Yeung, Cindy
    Bonanad Boix, Santiago
    Morales, Juan Cristobal
    Ozelo, Margareth C.
    Megias Vericat, Juan E.
    Iorio, Alfonso
    Spears, Jeffrey
    Mir, Roser
    Edginton, Andrea N.
    BLOOD, 2018, 132
  • [30] Population pharmacokinetic and pharmacodynamic (PK-PD) parameters of Erwinia Chrysanthemi (ERW) asparaginase (ASNase) using the fused first-order elimination and Michaelis-Menten (MM) limited physiological model
    Avramis, V. I.
    Fu, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
1234